MIJ is pleased to announce that we have recently invested in Hoba Therapeutics ApS.

Hoba Therapeutics is dedicated to innovative treatments for chronic pain disorders and sensorineural hearing loss- indications with a high unmet medical need for safe and efficacious treatments for millions of patients worldwide.

This financing was co-led by Indaco Venture Partners and our company, and also includes investment from the European Innovation Council Fund (EICF) along with current investors Novo Holdings, Eir Ventures, and the Export and Investment Fund of Denmark Eksport – og Investeringsfond (EIFO).

Hoba Therapeutics’ programs will yield significant positive impacts on pain management and related therapies.